14-24307013-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_174913.3(NOP9):​c.*1918T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.139 in 249,348 control chromosomes in the GnomAD database, including 3,851 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 1875 hom., cov: 32)
Exomes 𝑓: 0.15 ( 1976 hom. )

Consequence

NOP9
NM_174913.3 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.106

Publications

6 publications found
Variant links:
Genes affected
NOP9 (HGNC:19826): (NOP9 nucleolar protein) Enables RNA binding activity. Predicted to be involved in ribosome biogenesis. Predicted to be part of 90S preribosome and preribosome, small subunit precursor. Predicted to be active in nucleolus. [provided by Alliance of Genome Resources, Apr 2022]
CIDEB (HGNC:1977): (cell death inducing DFFA like effector b) Enables identical protein binding activity. Involved in activation of cysteine-type endopeptidase activity; positive regulation of cell death; and positive regulation of release of cytochrome c from mitochondria. Acts upstream of or within apoptotic process. Located in cytosol and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
LTB4R2 (HGNC:19260): (leukotriene B4 receptor 2) Predicted to enable G protein-coupled peptide receptor activity and leukotriene B4 receptor activity. Predicted to be involved in inflammatory response and neuropeptide signaling pathway. Predicted to act upstream of or within keratinocyte migration and signal transduction. Located in nucleoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.513 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOP9NM_174913.3 linkc.*1918T>C 3_prime_UTR_variant Exon 10 of 10 ENST00000267425.8 NP_777573.1
CIDEBNM_001393339.1 linkc.186+358A>G intron_variant Intron 2 of 4 ENST00000554411.6 NP_001380268.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOP9ENST00000267425.8 linkc.*1918T>C 3_prime_UTR_variant Exon 10 of 10 1 NM_174913.3 ENSP00000267425.3
CIDEBENST00000554411.6 linkc.186+358A>G intron_variant Intron 2 of 4 1 NM_001393339.1 ENSP00000451089.1

Frequencies

GnomAD3 genomes
AF:
0.130
AC:
19795
AN:
152068
Hom.:
1879
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0805
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.130
Gnomad ASJ
AF:
0.146
Gnomad EAS
AF:
0.529
Gnomad SAS
AF:
0.287
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.130
Gnomad NFE
AF:
0.110
Gnomad OTH
AF:
0.122
GnomAD4 exome
AF:
0.154
AC:
14934
AN:
97162
Hom.:
1976
Cov.:
0
AF XY:
0.156
AC XY:
7850
AN XY:
50446
show subpopulations
African (AFR)
AF:
0.0612
AC:
207
AN:
3380
American (AMR)
AF:
0.151
AC:
759
AN:
5030
Ashkenazi Jewish (ASJ)
AF:
0.141
AC:
453
AN:
3218
East Asian (EAS)
AF:
0.588
AC:
3394
AN:
5772
South Asian (SAS)
AF:
0.240
AC:
2070
AN:
8614
European-Finnish (FIN)
AF:
0.180
AC:
854
AN:
4750
Middle Eastern (MID)
AF:
0.0936
AC:
44
AN:
470
European-Non Finnish (NFE)
AF:
0.107
AC:
6395
AN:
60040
Other (OTH)
AF:
0.129
AC:
758
AN:
5888
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
571
1141
1712
2282
2853
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
120
240
360
480
600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.130
AC:
19779
AN:
152186
Hom.:
1875
Cov.:
32
AF XY:
0.139
AC XY:
10379
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.0804
AC:
3340
AN:
41532
American (AMR)
AF:
0.130
AC:
1990
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.146
AC:
508
AN:
3470
East Asian (EAS)
AF:
0.529
AC:
2733
AN:
5166
South Asian (SAS)
AF:
0.286
AC:
1377
AN:
4822
European-Finnish (FIN)
AF:
0.191
AC:
2025
AN:
10586
Middle Eastern (MID)
AF:
0.136
AC:
40
AN:
294
European-Non Finnish (NFE)
AF:
0.110
AC:
7487
AN:
67984
Other (OTH)
AF:
0.119
AC:
251
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
820
1640
2460
3280
4100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.115
Hom.:
363
Bravo
AF:
0.124
Asia WGS
AF:
0.381
AC:
1325
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.8
DANN
Benign
0.63
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2332320; hg19: chr14-24776219; API